Lv4
460 积分 2022-02-22 加入
Discovering C3 targeting therapies for paroxysmal nocturnal hemoglobinuria: Achievements and pitfalls
3小时前
待确认
The role of complement in kidney disease
5小时前
已完结
RANO 2.0: Update to the Response Assessment in Neuro-Oncology Criteria for High- and Low-Grade Gliomas in Adults
3个月前
已完结
Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial
4个月前
已完结
POS0230 DISAGREEMENT BETWEEN PATIENT AND PHYSICIAN GLOBAL ASSESSMENT OVER TIME IN PSORIATIC ARTHRITIS: INSIGHT INTO TREATMENT PRIORITIES
4个月前
已完结
Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial
4个月前
已完结
Repotrectinib: First Approval
4个月前
已完结
Efficacy and Safety of Elafibranor in Primary Biliary Cholangitis
5个月前
已完结
Stem Cell-based Therapy Strategy for Hepatic Fibrosis by Targeting Intrahepatic Cells
7个月前
已完结
Natural history of idiopathic pulmonary fibrosis
7个月前
已完结
皖公网安备34019202002308
